Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.2K
Abnormal Proliferation02:23

Abnormal Proliferation

5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
Cancer Therapies02:49

Cancer Therapies

9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Correction: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.

Cancer discovery·2025
Same author

Multidimensional, integrative profiling identifies BCL2L1 methylation as a predictor of MCL1 dependency in pediatric malignancies.

JCI insight·2025
Same author

A STAT3-STING-IFN axis controls the metastatic spread of small cell lung cancer.

Nature immunology·2024
Same author

A Semiautomated Proteomics and Phosphoproteomics Protocol for the Identification of Novel Therapeutic Targets and Predictive Biomarkers in In Vivo Xenograft Models of Pediatric Cancers.

Methods in molecular biology (Clifton, N.J.)·2024
Same author

Post-COVID-19 approach to teaching an undergraduate laboratory class focused on experimental design and data interpretation.

Biochemistry and molecular biology education : a bimonthly publication of the International Union of Biochemistry and Molecular Biology·2024
Same author

PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma.

The Journal of clinical investigation·2024

相关实验视频

Updated: Jan 17, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.6K

针对儿童肉瘤的发育脆弱性.

Elise Young1,2,3,4, Barnaby Kelly1,2, Jason E Cain5,6,7

  • 1Hudson Institute of Medical Research, 27-31 Wright St, Clayton, Victoria, 3168, Australia.

Cancer metastasis reviews
|September 22, 2025
PubMed
概括

儿童肉瘤是具有很低生存率的侵袭性儿科固体瘤. 本综述探讨了破坏发育途径如何驱动肉瘤生长,并讨论了针对这些脆弱性的新疗法.

关键词:
儿童癌症 儿童癌症发展途径的发展途径.肉瘤肉瘤是一种肉瘤.信号传输 信号传输治疗方法 治疗方法

更多相关视频

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.6K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.9K

相关实验视频

Last Updated: Jan 17, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

19.6K
Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.6K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.9K

科学领域:

  • 儿科瘤学 儿科瘤学
  • 发育生物学 发展生物学
  • 癌症分子机制 癌症分子机制

背景情况:

  • 儿童瘤是侵袭性的细胞间瘤,占儿科固体瘤的三分之一以上.
  • 治疗进展有限,导致长期幸存者的生存率低下和高发病率.
  • 儿科肉瘤起源于发育中的组织,与发育窗口中被捕的原始原生细胞共享特征.

研究的目的:

  • 审查驱动儿科肉瘤发生的分子机制.
  • 突出发展规划中断在肉瘤发病和进展中的作用.
  • 讨论针对儿童肉瘤发育脆弱性的新兴治疗策略.

主要方法:

  • 关于儿科肉瘤发生的当前文献的综述.
  • 分析分子机制,包括表观遗传调节,胚胎信号和生长途径.
  • 检查与组织发育相关的年龄特定发病率.

主要成果:

  • 扭曲的发育编程,包括表观遗传失调和异常信号通路,是儿科肉瘤发生的核心原因.
  • 瘤发病率模式反映了特定于年龄的组织扩张和生长动态.
  • 了解发育起源为我们提供了关于肉瘤异质性的见解.

结论:

  • 针对发育脆弱性,为新的儿科肉瘤疗法提供了一个有希望的途径.
  • 进一步研究发育重编程的分子基础对于改善治疗结果至关重要.
  • 新的治疗策略旨在利用儿童瘤的独特发育依赖性.